The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle

Extensive studies of human T-cell leukemia virus (HTLV)-1 and HTLV-2 over the last three decades have provided detailed knowledge on viral transformation, host–viral interactions and pathogenesis. HTLV-1 is the etiological agent of adult T cell leukemia and multiple neurodegenerative and inflammatory diseases while HTLV-2 disease association remains elusive, with few infected individuals displaying neurodegenerative diseases similar to HTLV-1. The HTLV group of oncoretroviruses has a genome that encodes structural and enzymatic proteins Gag, Pro, and Env, regulatory proteins Tax and Rex, and several accessory proteins from the pX region. Of these proteins, HTLV-1 p30 and HTLV-2 p28 are encoded by the open reading frame II of the pX region. Like most other accessory proteins, p30 and p28 are dispensable for in vitro viral replication and transformation but are required for efficient viral replication and persistence in vivo. Both p30 and p28 regulate viral gene expression at the post-transcriptional level whereas p30 can also function at the transcriptional level. Recently, several reports have implicated p30 and p28 in multiple cellular processes, which provide novel insight into HTLV spread and survival and ultimately pathogenesis. In this review we summarize and compare what is known about p30 and p28, highlighting their roles in viral replication and viral pathogenesis.

[1]  L. Ratner,et al.  Human T-Cell Lymphotropic Virus Type 1 Open Reading Frame II-Encoded p30II Is Required for In Vivo Replication: Evidence of In Vivo Reversion , 2004, Journal of Virology.

[2]  K. Jeang,et al.  A Human T-cell Leukemia Virus Tax Variant Incapable of Activating NF-κB Retains Its Immortalizing Potential for Primary T-lymphocytes* , 1998, The Journal of Biological Chemistry.

[3]  K. Jeang,et al.  Molecular mechanisms of cellular transformation by HTLV-1 Tax , 2005, Oncogene.

[4]  M. Osame,et al.  Antibody reactivities to tumor‐suppressor protein p53 and HTLV‐I Tof, Rex and Tax in HTLV‐I‐infected people with differing clinical status , 1997, International journal of cancer.

[5]  T. Misteli,et al.  HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication , 2004, Nature Medicine.

[6]  W. Ding,et al.  Human T-Lymphotropic Virus Type 1 p30IIFunctions as a Transcription Factor and Differentially Modulates CREB-Responsive Promoters , 2000, Journal of Virology.

[7]  K. Raska [GLOBAL EPIDEMIOLOGY]. , 1964, Ceskoslovenska epidemiologie, mikrobiologie, imunologie.

[8]  J. Desmyter,et al.  HTLV-II among pygmies , 1992, Nature.

[9]  W. Blattner,et al.  Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Anupam,et al.  Human T-lymphotropic Virus Type 1 p30 Interacts with REGγ and Modulates ATM (Ataxia Telangiectasia Mutated) to Promote Cell Survival* , 2011, The Journal of Biological Chemistry.

[11]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.

[12]  M. Cole,et al.  A Human T-Cell Lymphotropic Virus Type 1 Enhancer of Myc Transforming Potential Stabilizes Myc-TIP60 Transcriptional Interactions , 2005, Molecular and Cellular Biology.

[13]  Joshua Arnold,et al.  Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. , 2006, Blood.

[14]  P. Green,et al.  Human T-Cell Leukemia Virus Open Reading Frame II Encodes a Posttranscriptional Repressor That Is Recruited at the Level of Transcription , 2006, Journal of Virology.

[15]  P. Mckinnon DNA repair deficiency and neurological disease , 2009, Nature Reviews Neuroscience.

[16]  Anke Busch,et al.  Evolution of SR protein and hnRNP splicing regulatory factors , 2012, Wiley interdisciplinary reviews. RNA.

[17]  L. Ratner,et al.  Immortalization of CD4+ and CD8+ T Lymphocytes by Human T-Cell Leukemia Virus Type 1 Tax Mutants Expressed in a Functional Molecular Clone , 1999, Journal of Virology.

[18]  K. Vermeulen,et al.  The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer , 2003, Cell proliferation.

[19]  L. Ratner,et al.  Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival , 2007, Retrovirology.

[20]  T. Ross,et al.  Human T-Cell Leukemia Virus Type 2 Tax Mutants That Selectively Abrogate NFκB or CREB/ATF Activation Fail To Transform Primary Human T Cells , 2000, Journal of Virology.

[21]  Adeeba Kamarulzaman,et al.  AIDS Res Hum Retroviruses , 2006 .

[22]  F. Proietti,et al.  Epidemiology, Treatment, and Prevention of Human T-Cell Leukemia Virus Type 1-Associated Diseases , 2010, Clinical Microbiology Reviews.

[23]  W. Heneine,et al.  HTLV-II endemicity among Guaymi Indians in Panama. , 1991, The New England journal of medicine.

[24]  M. Lairmore,et al.  Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo , 2008, Retrovirology.

[25]  S. Landry,et al.  Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription. , 2009, Blood.

[26]  G. de Thé,et al.  Evidence of HTLV-II infection in Guinea, West Africa. , 1993, Journal of acquired immune deficiency syndromes.

[27]  I. Koralnik,et al.  The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments , 1993, Journal of virology.

[28]  M. Reitz,et al.  Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Greene,et al.  Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. , 1990, Genes & development.

[30]  L. Chieco‐Bianchi,et al.  Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. , 1995, Virology.

[31]  P. Green,et al.  The human T-cell leukemia virus Rex protein. , 2005, Frontiers in bioscience : a journal and virtual library.

[32]  F. Ruscetti,et al.  X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. , 1997, Virology.

[33]  C. Nicot,et al.  HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression , 2010, Molecular Cancer.

[34]  E. Murphy,et al.  Global epidemiology of HTLV-I infection and associated diseases , 2005, Oncogene.

[35]  M. Yoshida,et al.  p27x-III and p21x-III, proteins encoded by the pX sequence of human T-cell leukemia virus type I. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Yu-Jie Hu,et al.  Versatility of PRMT5-induced methylation in growth control and development. , 2011, Trends in biochemical sciences.

[37]  I. Chen,et al.  A deletion in the proximal untranslated pX region of human T-cell leukemia virus type II decreases viral replication but not infectivity in vivo. , 1996, Blood.

[38]  Mitsuaki Yoshida Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis , 2005, Oncogene.

[39]  Kuan-Teh Jeang,et al.  Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation , 2007, Nature Reviews Cancer.

[40]  K. Takatsuki,et al.  Discovery of adult T-cell leukemia , 2005, Retrovirology.

[41]  L. Ratner,et al.  Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity. , 2006, Virology.

[42]  R. Anupam,et al.  Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28: insights into difference in pathobiology of human retroviruses , 2012, Retrovirology.

[43]  A. Vandamme,et al.  HTLV-II seroprevalence in pygmies across Africa since 1970. , 1993, AIDS research and human retroviruses.

[44]  M. Biard-Piechaczyk,et al.  The Complementary Strand of the Human T-Cell Leukemia Virus Type 1 RNA Genome Encodes a bZIP Transcription Factor That Down-Regulates Viral Transcription , 2002, Journal of Virology.

[45]  Joshua Arnold,et al.  Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. , 2008, Blood.

[46]  S. Buch,et al.  The HTLV-I p30 Interferes with TLR4 Signaling and Modulates the Release of Pro- and Anti-inflammatory Cytokines from Human Macrophages* , 2006, Journal of Biological Chemistry.

[47]  N. Clark,et al.  Direct Evidence , 1934 .

[48]  Massimo Caputi,et al.  SR proteins and hnRNP H regulate the splicing of the HIV‐1 tev‐specific exon 6D , 2002, The EMBO journal.

[49]  P. Green,et al.  Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR. , 2007, Journal of virological methods.

[50]  L. Gazzolo,et al.  Regulation of the human T-cell leukemia virus gene expression depends on the localization of regulatory proteins Tax, Rex and p30II in specific nuclear subdomains. , 2007, Gene.

[51]  G. Pavlakis,et al.  The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. , 1985, Science.

[52]  A. Rosato,et al.  The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex , 1997, Journal of virology.

[53]  P. Mckinnon DNA repair deficiency and neurological disease , 2009, Nature Reviews Neuroscience.

[54]  D. McFarlin,et al.  HTLV‐I‐specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV‐I‐associated neurological disease , 1992, Annals of neurology.

[55]  A. Ureta-Vidal,et al.  Evidence for the Chronic in Vivo Production of Human T Cell Leukemia Virus Type I Rof and Tof Proteins from Cytotoxic T Lymphocytes Directed against Viral Peptides , 2000, The Journal of experimental medicine.

[56]  C. Nicot,et al.  Human T-cell Lymphotrophic Virus Type I Rex and p30 Interactions Govern the Switch between Virus Latency and Replication* , 2007, Journal of Biological Chemistry.

[57]  B. Hjelle,et al.  High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: determination by sequence-specific oligonucleotide hybridization. , 1990, Blood.

[58]  M. Dundr,et al.  Repression of Human T-Cell Leukemia Virus Type 1 and Type 2 Replication by a Viral mRNA-Encoded Posttranscriptional Regulator , 2004, Journal of Virology.

[59]  I. Chen,et al.  Regulation of human T cell leukemia virus , 1990 .

[60]  J. Bartek,et al.  The DNA-damage response in human biology and disease , 2009, Nature.

[61]  M. Dundr,et al.  PA28γ is a novel corepressor of HTLV-1 replication and controls viral latency. , 2013, Blood.

[62]  Christophe Nicot,et al.  Genome wide analysis of human genes transcriptionally and post-transcriptionally regulated by the HTLV-I protein p30 , 2009, BMC Genomics.

[63]  G. Draetta,et al.  Cdc25 protein phosphatases in cell proliferation. , 1997, Biochimica et biophysica acta.

[64]  F. Ruscetti,et al.  Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. , 2010, Blood.

[65]  Z. Berneman,et al.  Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[66]  G. Pavlakis,et al.  Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I , 1992, Journal of virology.

[67]  L. Ratner,et al.  Functional Role of pX Open Reading Frame II of Human T-Lymphotropic Virus Type 1 in Maintenance of Viral Loads In Vivo , 2000, Journal of Virology.

[68]  M. Yoshida,et al.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Prabhakar R. Gudla,et al.  Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission , 2010, Proceedings of the National Academy of Sciences.

[70]  J. Drummond,et al.  HTLV-II infection in Florida Indians. , 1993, AIDS research and human retroviruses.

[71]  C. Stevens,et al.  Aquaporin 4 and glymphatic flow have central roles in brain fluid homeostasis , 2021, Nature Reviews Neuroscience.

[72]  M. Yoshida,et al.  Direct evidence that p40x of human T‐cell leukemia virus type I is a trans‐acting transcriptional activator. , 1986, The EMBO journal.

[73]  C. Casoli,et al.  Temporal regulation of HTLV-2 expression in infected cell lines and patients: evidence for distinct expression kinetics with nuclear accumulation of APH-2 mRNA , 2012, Retrovirology.

[74]  W. Hall,et al.  Human T‐lymphotropic virus type II and neurological disease , 2004, Annals of neurology.

[75]  A. Poustka,et al.  Systematic subcellular localization of novel proteins identified by large‐scale cDNA sequencing , 2000, EMBO reports.

[76]  M. Vidal,et al.  Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses , 2012, Retrovirology.

[77]  M. Dundr,et al.  Human T-cell Leukemia Virus Type I p30 Nuclear/Nucleolar Retention Is Mediated through Interactions with RNA and a Constituent of the 60 S Ribosomal Subunit* , 2006, Journal of Biological Chemistry.

[78]  K. Yamaguchi,et al.  Adult T-Cell Leukemia: A Review of Epidemiological Evidence , 2012, Front. Microbio..

[79]  A. Corradin,et al.  Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. , 2011, Blood.

[80]  M. Lairmore,et al.  Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes , 2004, Retrovirology.

[81]  Ross Smith,et al.  Functional diversity of the hnRNPs: past, present and perspectives. , 2010, The Biochemical journal.

[82]  F. Kashanchi,et al.  Human T-Lymphotropic Virus Type 1 p30IIRegulates Gene Transcription by Binding CREB Binding Protein/p300 , 2001, Journal of Virology.

[83]  R. Anupam,et al.  Mechanisms of human T-lymphotropic virus type 1 transmission and disease. , 2012, Current opinion in virology.

[84]  C. Nicot,et al.  Human T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA repair. , 2011, Blood.

[85]  Sharmistha Pal,et al.  Protein Arginine Methyltransferase 5 Suppresses the Transcription of the RB Family of Tumor Suppressors in Leukemia and Lymphoma Cells , 2008, Molecular and Cellular Biology.

[86]  L. Ratner,et al.  Human T-Cell Leukemia Virus Type 1 pX-I and pX-II Open Reading Frames Are Dispensable for the Immortalization of Primary Lymphocytes , 1998, Journal of Virology.